Rankings
▼
Calendar
VTYX FY 2024 Earnings — Ventyx Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
VTYX
Ventyx Biosciences, Inc.
$1B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$148M
Net Income
-$135M
EPS (Diluted)
$-1.97
Cash Flow
Operating Cash Flow
-$131M
Free Cash Flow
-$131M
Stock-Based Comp.
$23M
Balance Sheet
Total Assets
$277M
Total Liabilities
$23M
Stockholders' Equity
$254M
Cash & Equivalents
$27M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$148M
-$208M
+28.6%
Net Income
-$135M
-$193M
+30.0%
← Q4 2023
All Quarters
Q1 2024 →